Proficio Capital Partners LLC purchased a new position in AdaptHealth Corp. (NASDAQ:AHCO – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 19,040 shares of the company’s stock, valued at approximately $181,000.
Other institutional investors have also added to or reduced their stakes in the company. Intech Investment Management LLC grew its position in shares of AdaptHealth by 223.2% in the 3rd quarter. Intech Investment Management LLC now owns 59,650 shares of the company’s stock worth $670,000 after buying an additional 41,196 shares during the period. Barclays PLC boosted its stake in AdaptHealth by 361.3% during the third quarter. Barclays PLC now owns 181,240 shares of the company’s stock worth $2,034,000 after acquiring an additional 141,949 shares in the last quarter. Principal Financial Group Inc. grew its holdings in AdaptHealth by 39.7% in the third quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock worth $6,106,000 after purchasing an additional 154,434 shares during the period. JPMorgan Chase & Co. increased its stake in shares of AdaptHealth by 73.2% during the third quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company’s stock valued at $2,154,000 after purchasing an additional 81,097 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of AdaptHealth by 7.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 162,470 shares of the company’s stock valued at $1,825,000 after purchasing an additional 11,757 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.
AdaptHealth Trading Up 1.5 %
Shares of NASDAQ:AHCO opened at $10.64 on Friday. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. AdaptHealth Corp. has a 1 year low of $8.35 and a 1 year high of $11.90. The company has a market cap of $1.43 billion, a P/E ratio of -6.45, a PEG ratio of 1.08 and a beta of 1.30. The stock’s fifty day moving average price is $10.02 and its 200-day moving average price is $10.17.
Analysts Set New Price Targets
Get Our Latest Research Report on AHCO
AdaptHealth Profile
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Featured Articles
- Five stocks we like better than AdaptHealth
- What Are the FAANG Stocks and Are They Good Investments?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- How to Profit From Growth Investing
- Top 3 Beverage Stocks Pouring Out Profits
- Using the MarketBeat Stock Split Calculator
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.